🇺🇸 Norethindrone acetate pretreatment in United States

FDA authorised Norethindrone acetate pretreatment on 21 April 1982

Marketing authorisations

FDA — authorised 21 April 1982

  • Application: NDA018405
  • Marketing authorisation holder: DURAMED RES
  • Local brand name: AYGESTIN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Norethindrone acetate pretreatment in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Norethindrone acetate pretreatment approved in United States?

Yes. FDA authorised it on 21 April 1982; FDA has authorised it.

Who is the marketing authorisation holder for Norethindrone acetate pretreatment in United States?

DURAMED RES holds the US marketing authorisation.